Article Details

Statera Biopharma : Announces Pricing of $2.0 Million Registered Direct Offering - MarketScreener

Retrieved on: 2022-02-08 02:12:19

Tags for this article:

Click the tags to see associated articles and topics

Statera Biopharma : Announces Pricing of $2.0 Million Registered Direct Offering - MarketScreener. View article details on hiswai:

Excerpt

(NASDAQ: STAB) (the "Company" or "Statera Biopharma"), a leading biopharmaceutical company creating next-generation immune therapies that focus on ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up